Vantis Vascular completes first commercial use of CrossFAST system
Vantis Vascular has completed the first commercial application of its CrossFAST Integrated Microcatheter Advanced Delivery System. The procedures were carried…
Cardiovascular
-
-
Pulse Biosciences touts positive results from PFA early feasibility study
Pulse Biosciences has reported positive results from a first-in-human feasibility study evaluating its nanosecond pulsed field ablation (nsPFA) technology for…
-
Johnson & Johnson MedTech’s Dual Energy Catheter gains CE mark approval
Johnson & Johnson MedTech’s Dual Energy THERMOCOOL SMARTTOUCH SF Catheter has gained the European CE mark approval for treating cardiac…
-
FIRE1 secures $120m in funding for heart failure sensor
FIRE1 has raised $120m in a financing round to advance its sensor that monitors important warning signs of heart failure…
-
AccurKardia’s AK+ Guard gains FDA breakthrough device status
AccurKardia has gained the US Food and Drug Administration's (FDA) breakthrough device designation for its AI-powered ‘AK+ Guard’ software, aimed…
-
Anumana and AliveCor to co-develop AI algorithms for cardiac disease detection
US-based health technology company Anumana has partnered with AliveCor for the development of its AI algorithms intended for the early…
-
Alleviant Medical wins IDE for no-implant atrial shunt device pivotal trial
The US Food and Drug Administration (FDA) has granted Alleviant Medical an investigational device exemption (IDE), enabling the company to…
-
CathWorks completes enrolment in CAD treatment system trial
CathWorks has completed the enrolment for a randomised controlled trial (RCT), evaluating the FFRangio system in diagnosing and treating coronary…
-
AI-driven adaptive cardiovascular devices show “personalised medicine shift”
The emergence of adaptive cardiac devices, especially those that utilise AI, is propelling the wider industry shift towards personalised medicine,…
-
FDA issues “high-risk” safety alert to Nuwellis blood circuit sets
The US Food and Drug Administration (FDA) has issued an alert relating to a problem with blood circuit sets manufactured…
